Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 10 | 2024 | 515 | 1.970 |
Why?
|
| Vaccination | 11 | 2025 | 275 | 0.900 |
Why?
|
| Poverty | 4 | 2023 | 207 | 0.880 |
Why?
|
| Adult | 35 | 2025 | 13561 | 0.840 |
Why?
|
| Military Personnel | 1 | 2025 | 163 | 0.810 |
Why?
|
| Stress, Psychological | 1 | 2025 | 268 | 0.800 |
Why?
|
| Patient Education as Topic | 4 | 2024 | 332 | 0.790 |
Why?
|
| Rural Population | 5 | 2024 | 556 | 0.780 |
Why?
|
| Reward | 2 | 2020 | 115 | 0.780 |
Why?
|
| Parents | 6 | 2025 | 320 | 0.750 |
Why?
|
| Communication Barriers | 1 | 2021 | 31 | 0.690 |
Why?
|
| Vaccines | 1 | 2021 | 50 | 0.670 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 127 | 0.630 |
Why?
|
| Urban Population | 1 | 2019 | 150 | 0.590 |
Why?
|
| Humans | 53 | 2025 | 50419 | 0.590 |
Why?
|
| Tobacco Use Disorder | 1 | 2020 | 170 | 0.570 |
Why?
|
| Decision Making | 1 | 2020 | 271 | 0.550 |
Why?
|
| Arkansas | 13 | 2025 | 1974 | 0.510 |
Why?
|
| Hypertension | 1 | 2021 | 545 | 0.500 |
Why?
|
| Male | 29 | 2025 | 25866 | 0.480 |
Why?
|
| Female | 30 | 2025 | 27053 | 0.480 |
Why?
|
| Immunization, Secondary | 2 | 2024 | 21 | 0.440 |
Why?
|
| Adolescent | 14 | 2025 | 6453 | 0.410 |
Why?
|
| Cross-Sectional Studies | 6 | 2025 | 1601 | 0.400 |
Why?
|
| United States | 12 | 2024 | 5005 | 0.380 |
Why?
|
| Young Adult | 9 | 2025 | 4075 | 0.380 |
Why?
|
| Qualitative Research | 2 | 2024 | 351 | 0.370 |
Why?
|
| Middle Aged | 17 | 2025 | 12579 | 0.370 |
Why?
|
| Obesity | 5 | 2023 | 1123 | 0.360 |
Why?
|
| Motivation | 3 | 2024 | 277 | 0.360 |
Why?
|
| Health Services Accessibility | 5 | 2024 | 426 | 0.350 |
Why?
|
| Community-Based Participatory Research | 3 | 2021 | 198 | 0.350 |
Why?
|
| Overweight | 2 | 2023 | 214 | 0.350 |
Why?
|
| Mothers | 2 | 2024 | 257 | 0.330 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2025 | 485 | 0.290 |
Why?
|
| Papillomavirus Vaccines | 2 | 2025 | 66 | 0.260 |
Why?
|
| Health Behavior | 4 | 2023 | 253 | 0.260 |
Why?
|
| Educational Status | 3 | 2023 | 225 | 0.260 |
Why?
|
| Genetic Counseling | 2 | 2023 | 41 | 0.260 |
Why?
|
| Telemedicine | 2 | 2024 | 468 | 0.250 |
Why?
|
| Papillomavirus Infections | 2 | 2025 | 165 | 0.250 |
Why?
|
| Intention | 2 | 2024 | 43 | 0.240 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2025 | 28 | 0.230 |
Why?
|
| Health Personnel | 2 | 2024 | 251 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 342 | 0.230 |
Why?
|
| Influenza, Human | 2 | 2022 | 86 | 0.220 |
Why?
|
| Child | 10 | 2025 | 6931 | 0.220 |
Why?
|
| Child, Preschool | 6 | 2024 | 3953 | 0.220 |
Why?
|
| Sleep | 2 | 2024 | 183 | 0.210 |
Why?
|
| School Admission Criteria | 1 | 2023 | 35 | 0.210 |
Why?
|
| Family | 2 | 2022 | 175 | 0.200 |
Why?
|
| Food Assistance | 1 | 2023 | 19 | 0.200 |
Why?
|
| Health Promotion | 2 | 2022 | 257 | 0.200 |
Why?
|
| Bullying | 1 | 2022 | 10 | 0.200 |
Why?
|
| Self Care | 2 | 2022 | 136 | 0.200 |
Why?
|
| Anxiety | 1 | 2025 | 285 | 0.200 |
Why?
|
| Child Care | 1 | 2022 | 16 | 0.200 |
Why?
|
| Aged | 11 | 2024 | 9738 | 0.190 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 31 | 0.190 |
Why?
|
| Racism | 1 | 2023 | 60 | 0.190 |
Why?
|
| Mass Vaccination | 1 | 2021 | 6 | 0.180 |
Why?
|
| Lunch | 1 | 2021 | 7 | 0.180 |
Why?
|
| Meals | 1 | 2021 | 61 | 0.170 |
Why?
|
| Inventions | 1 | 2020 | 9 | 0.170 |
Why?
|
| Attitude to Computers | 1 | 2020 | 16 | 0.170 |
Why?
|
| Depression | 1 | 2025 | 577 | 0.160 |
Why?
|
| Self Efficacy | 1 | 2021 | 136 | 0.160 |
Why?
|
| Nursing Staff, Hospital | 1 | 2020 | 34 | 0.160 |
Why?
|
| Dermatofibrosarcoma | 1 | 2019 | 8 | 0.160 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 24 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2021 | 201 | 0.160 |
Why?
|
| Methylphenidate | 1 | 2019 | 76 | 0.150 |
Why?
|
| Attention | 1 | 2019 | 165 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2021 | 525 | 0.150 |
Why?
|
| Parenting | 1 | 2019 | 101 | 0.150 |
Why?
|
| Intensive Care Units | 1 | 2020 | 228 | 0.150 |
Why?
|
| Quality of Life | 1 | 2024 | 850 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2020 | 389 | 0.150 |
Why?
|
| Culture | 1 | 2018 | 53 | 0.140 |
Why?
|
| Critical Care | 1 | 2020 | 214 | 0.140 |
Why?
|
| Preventive Health Services | 1 | 2018 | 49 | 0.140 |
Why?
|
| Emergency Medical Services | 1 | 2018 | 110 | 0.140 |
Why?
|
| Religion | 1 | 2018 | 62 | 0.140 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 73 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 170 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2020 | 694 | 0.140 |
Why?
|
| Patient Participation | 1 | 2018 | 73 | 0.140 |
Why?
|
| Health Services Research | 1 | 2018 | 149 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 209 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 352 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 305 | 0.120 |
Why?
|
| Child Abuse | 1 | 2017 | 130 | 0.120 |
Why?
|
| Child Development | 1 | 2017 | 192 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 402 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 281 | 0.110 |
Why?
|
| Heterosexuality | 1 | 2014 | 9 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 492 | 0.110 |
Why?
|
| Psychological Tests | 1 | 2014 | 49 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2020 | 2378 | 0.110 |
Why?
|
| Food Supply | 2 | 2024 | 90 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 1248 | 0.090 |
Why?
|
| Comparative Effectiveness Research | 2 | 2024 | 44 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 567 | 0.090 |
Why?
|
| Evidence-Based Practice | 2 | 2022 | 98 | 0.090 |
Why?
|
| Prevalence | 2 | 2024 | 967 | 0.090 |
Why?
|
| Body Mass Index | 2 | 2024 | 674 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 386 | 0.080 |
Why?
|
| Weight Loss | 2 | 2023 | 245 | 0.070 |
Why?
|
| Time Factors | 3 | 2020 | 2933 | 0.070 |
Why?
|
| Infant | 3 | 2022 | 3648 | 0.070 |
Why?
|
| Exercise | 2 | 2023 | 513 | 0.070 |
Why?
|
| Pandemics | 2 | 2021 | 553 | 0.070 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 280 | 0.060 |
Why?
|
| Logistic Models | 2 | 2018 | 901 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 3233 | 0.060 |
Why?
|
| Community Health Workers | 1 | 2024 | 50 | 0.060 |
Why?
|
| Micronesia | 1 | 2024 | 106 | 0.060 |
Why?
|
| Public Policy | 1 | 2023 | 35 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2024 | 275 | 0.050 |
Why?
|
| Consciousness | 1 | 2023 | 20 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 263 | 0.050 |
Why?
|
| Bereavement | 1 | 2022 | 12 | 0.050 |
Why?
|
| Friends | 1 | 2022 | 20 | 0.050 |
Why?
|
| Hawaii | 1 | 2023 | 118 | 0.050 |
Why?
|
| Jurisprudence | 1 | 2022 | 10 | 0.050 |
Why?
|
| Law Enforcement | 1 | 2022 | 9 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 3712 | 0.050 |
Why?
|
| Medicare | 1 | 2024 | 247 | 0.050 |
Why?
|
| Attitude | 1 | 2022 | 67 | 0.050 |
Why?
|
| Self Report | 1 | 2023 | 206 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 591 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2021 | 23 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2021 | 120 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 1118 | 0.040 |
Why?
|
| Cholesterol | 1 | 2021 | 150 | 0.040 |
Why?
|
| Trust | 1 | 2021 | 60 | 0.040 |
Why?
|
| Breakfast | 1 | 2021 | 15 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2021 | 97 | 0.040 |
Why?
|
| Fear | 1 | 2021 | 83 | 0.040 |
Why?
|
| Communication | 1 | 2022 | 256 | 0.040 |
Why?
|
| Self-Help Groups | 1 | 2019 | 15 | 0.040 |
Why?
|
| Mohs Surgery | 1 | 2019 | 15 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2021 | 190 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 240 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 340 | 0.040 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 51 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2021 | 183 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 66 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 732 | 0.040 |
Why?
|
| Reaction Time | 1 | 2019 | 212 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 60 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2019 | 125 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6274 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 346 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 204 | 0.040 |
Why?
|
| Social Media | 1 | 2019 | 99 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 374 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1181 | 0.030 |
Why?
|
| Life Change Events | 1 | 2017 | 35 | 0.030 |
Why?
|
| Physical Fitness | 1 | 2017 | 60 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 550 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 976 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 622 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 1268 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2752 | 0.030 |
Why?
|
| Cognition | 1 | 2017 | 342 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2018 | 300 | 0.030 |
Why?
|
| Diet | 1 | 2018 | 564 | 0.030 |
Why?
|
| Homosexuality, Female | 1 | 2014 | 7 | 0.030 |
Why?
|
| Religion and Psychology | 1 | 2014 | 27 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2014 | 51 | 0.030 |
Why?
|
| Digital Rectal Examination | 1 | 2013 | 3 | 0.030 |
Why?
|
| Kallikreins | 1 | 2013 | 18 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 44 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 162 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5265 | 0.020 |
Why?
|